⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001827272

Tester Jason E.

Reports to the SEC for 1 company · IRVINE, CA

Transactions

14

Companies

1

Filings

2

CIK

0001827272

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+21.6K sh	—	—	21,575
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+3,698 sh	—	—	25,273
2020-10-20	TARSTarsus Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+3,125 sh	$16.00	+$50K	28,398
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.43M sh	—	—	1,434,790
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+246K sh	—	—	1,680,756
2020-10-20	TARSTarsus Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+71.4K sh	—	—	1,752,183
2020-10-20	TARSTarsus Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+169K sh	$16.00	+$2.7M	1,920,933
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−21.6K sh	—	—	0
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−3,698 sh	—	—	0
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.43M sh	—	—	0
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−246K sh	—	—	0
2020-10-20	TARSTarsus Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−71.4K sh	—	—	0

Recent filings

2

Accepted (ET)
Jun 174
Tester Jason E.0001209191-21-041713
SEC(opens sec.gov)
Oct 204
Tester Jason E.0001209191-20-055421
SEC(opens sec.gov)

Companies

1

Tarsus Pharmaceuticals, Inc.Director, 10% OwnerTARS

Address

C/OTARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618